Primary hyperoxaluriatype 1: description of the clinical case


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The clinical experience of management of a patient with hereditary hyperoxaluria type 1 is described. Primary hyperoxaluria (oxalosis) is a rare autosomal recessive disease, manifested by diffuse deposition of calcium salts in interstitium, glomeruli and walls of renal arterioles, accompanied by sclerotic changes and development of renal failure. The article presents the pathogenetic aspects of the development of nephrocalcinosis in hyperoxaluria. The need for timely diagnosis and the appointment of adequate therapy in order to slow the progression of the pathological process in the kidney tissue is demonstrated

Full Text

Restricted Access

About the authors

M. P Safonova

SABU FSBEI HE RNSMU n.a. N.I. Pirogov of RMH "Scientific Research Clinical Institute of Pediatrics named after Academician Yu.E. Veltishchev"

Email: marinasafonova7@mail.ru
PhD in Medical Sciences, Leading Researcher at the Department of Radiation Ecopathology of Childhood

V. V Dlin

SABU FSBEI HE RNSMU n.a. N.I. Pirogov of RMH "Scientific Research Clinical Institute of Pediatrics named after Academician Yu.E. Veltishchev"

Email: vvdlin@mail.ru
Doctor of Medical Sciences, Professor, Acting Director

E. A Potrokhova

SABU FSBEI HE RNSMU n.a. N.I. Pirogov of RMH "Scientific Research Clinical Institute of Pediatrics named after Academician Yu.E. Veltishchev"

Email: potroshova@mail.ru
Doctor of Medical Sciences, Professor, Leading Researcher at the Department of Radiation Ecopathology of Childhood

L. S Baleva

SABU FSBEI HE RNSMU n.a. N.I. Pirogov of RMH "Scientific Research Clinical Institute of Pediatrics named after Academician Yu.E. Veltishchev"

Email: baleva@pedklinl.ru
Doctor of Medical Sciences, Professor, Head of the Children's Scientific and Practical Center for Radiation Protection

References

  1. Cochat P., Deloraine A., Rolity M., Olive F., Liponski I., Deries N. Epidemiology of primary hyperoxaluria type 1. Nephrol. Dial. Transplant. 1995; 10(8): 3-7.
  2. Van der Hoeven S.M., van Woerden C.S., Groothoff J.W. Primary hyperoxaluria type 1, a too often missed diagnosis and potentially treatable cause of endstage renal disease in adults: results of the Dutch cohort. Nephrol. Dial. Transplant. 2012; 27(10): 3855-62. doi: 10.1093/ndt/gfs320.
  3. Длин В.В., Османов И.М., Юрьева Э.А., Новиков П.В. Дизметаболическая нефропатия, мочекаменная болезнь и нефрокальциноз у детей. М., 2009; 134-137.
  4. Bollee G., Cochat P., Daudon M. Recurrence of crystalline nephropathy after kidney transplantation in aprt deficiency and primary hyperoxaluria. Canadian J. of Kidney Health and Disease. 2015; 2: 31.
  5. Hoppe B. An update on primary hyperoxaluria. Nat. Rev. Nephrol. 2012; 8(8): 467-75. doi: 10.1038/nrneph.2012.113.
  6. Lieske J.C., Monico C.G., Holmes W.S., Bergstralh E.J., Slezak J.M., Rohlinger A.L., Olson J.B., Milliner D.S. International registry for primary hyperoxaluria. Am. J. Nephrol. 2005; 25(3): 290-6. doi: 10.1159/000086360.
  7. Monico C.G., Rossetti S., Olson J.B., Milliner D.S. Pyridoxine effect in type I primary hyperoxaluria is associated with the most common mutant allele. Kidney Int. 2005; 67: 1704-1709.
  8. Coward R. Epidemiology of paediatric renal stone disease in the UK. Arch. Dis. Child. 2003; 88: 962-965.
  9. Edvardsson V., Palsson R., Olafsson I., Hjaltadottir G., Laxdal T. Clinical features and genotype of adenine phosphoribosyltransferase deficiency in iceland. Am. J. Kidney Dis. 2001; 38(3): 473-80. doi: 10.1053/ajkd.2001.26826.
  10. Harambat J., Fargue S., Acquaviva C., Gagnadoux M.F., Janssen F., Liutkus A., Mourani C., Macher M.A., Abramowicz D, Legendre C., Durrbach A., Tsimaratos M., Nivet H., Girardin E., Schott A.M., Rolland M.O., Cochat P. Genotype-phenotype correlation in primary hyperoxaluria type 1: The p.Gly170Arg AGXT mutation is associated with a better outcome. Kidney Int. 2010; 77: 443-449.
  11. Cochat P., Rumsby G. Primary hyperoxaluria. N. Engl. J. Med. 2013; 369(7): 649-58. doi: 10.1056/NEJMra1301564.
  12. Игнатова М.С., Вельтищев Ю.Е. Детская нефрология. Руководство для врачей. Л., 1989.
  13. Bollee G., Dollinger C., Boutaud L., Guillemot D., Bensman A., Harambat J., Deteix P., Daudon M., Knebelmann B., Ceballos-Picot I. Phenotype and genotype characterization of adenine phosphoribosyltransferase deficiency. J. Am. Soc. Nephrol. 2010; 21(4): 679-88. doi: 10.1681/ASN.2009080808.
  14. Weerakkody R.M. Primary hyperoxaluria type I importance of pretransplant genetic screening/ Saudi J Kidney Dis Transpl. 2016 Nov-Dec;27(6):1283-1284.
  15. Williams E.L., Acquaviva C., Amoroso A., et al., Primary hyperoxaluria type 1: update and additional mutation analysis of the AGXT gene, Hum. Mutat. 30; (2009). 910e917.
  16. Lorenz E.C., Lieske J.C., Seide B.M., Meek A.M., Olson J.B., Bergstralh E.J., Milliner D.S. Sustained pyridoxine response in primary hyperoxaluria type 1 recipients of kidney alone transplant, Am. J. Transpl. 14;(2014). 1433e1438.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies